This report provides an in depth analysis of the US left atrial appendage closure device market by value, by product, by procedure, by end-user, etc. The report also provides a detailed analysis of the COVID-19 impact on the left atrial appendage closure device market.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall left atrial appendage closure device market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The US left atrial appendage closure device market is fragmented with many major market players operating worldwide. The key players of the left atrial appendage closure device market are Johnson & Johnson, Abbott, Boston Scientific and Atricure are also profiled with their financial information and respective business strategies.
The US left atrial appendage closure device market is fragmented with many major market players operating worldwide. The key players of the left atrial appendage closure device market are Johnson & Johnson, Abbott, Boston Scientific and Atricure are also profiled with their financial information and respective business strategies.
Country Coverage
- The US
Company Coverage
- Johnson & Johnson
- Abbott
- Boston Scientific
- Atricure
Frequently Asked Questions about the US Left Atrial Appendage Closure Device Market
What is the estimated value of the US Left Atrial Appendage Closure Device Market?
What is the growth rate of the US Left Atrial Appendage Closure Device Market?
What is the forecasted size of the US Left Atrial Appendage Closure Device Market?
Who are the key companies in the US Left Atrial Appendage Closure Device Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 70 |
| Published | September 2021 |
| Forecast Period | 2021 - 2025 |
| Estimated Market Value ( USD | $ 265.32 Million |
| Forecasted Market Value ( USD | $ 645.89 Million |
| Compound Annual Growth Rate | 24.9% |
| Regions Covered | United States |
| No. of Companies Mentioned | 4 |
Table of Contents
1. Executive Summary
2. Introduction
3. The US Market Analysis
4. Impact of COVID-19
5. Market Dynamics
6. Competitive Landscape
7. Company Profiles
List of Figures
Executive Summary
Left atrial appendage closure is a nominal invading surgery that is done to decrease the chance of stroke that happens due to atrial fibrillation (also called as Afib or AF). Left atrial appendage closure is also called LAAC or LAA closure. Atrial fibrillation is a usual type of arrhythmia, a situation in which human heart beats out of rhythm. LAA closure equipment provides blood clot control as a substitute to blood thinners.The US Left atrial appendage closure device market can be segmented on the basis of product, endoscopes, Epicardial left atrial appendage closure device and endocardial left atrial appendage closure device; on the basis of procedure, such as percutaneous and surgical and on the basis of end-users, such as hospitals, ambulatory surgery centres and others.
The US left atrial appendage closure device market has increased significantly during the years 2016-2020 and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The left atrial appendage closure device market is expected to increase due to aging population, growing gross national income, increasing prevalence of atrial fibrillation, increasing healthcare spending worldwide, growing urbanization and rising adoption of minimally invasive procedure. Yet, the market faces some challenges such as high cost of left atrial appendage closure procedure & equipment, unfavorable reimbursement policies in developing countries and high degree of competition.
The COVID-19 pandemic had a positive impact on the market because when restrictions were lifted people were getting their procedures done immediately as heart patients have lower survival chances if they catch coronavirus.
Companies Mentioned
- Johnson & Johnson
- Abbott
- Boston Scientific
- Atricure
